Biocon Biologics gets US FDA nod for two drugs to treat osteoporosis, bone loss

Shares of the company ended 1.6% lower at a price of ₹354.40 on the BSE. Last week’s losses have dragged the stock 4% lower for the year-to-date.

Leave a Reply

Your email address will not be published. Required fields are marked *